Cambridge Healthtech Institute’s 6th Annual

Oligonucleotide CMC & Regulatory Strategies

Enhancing Analytical and Manufacturing Methods and Accelerating Time to Market

March 13-14, 2024

Cambridge Healthtech Institute's conference on Oligonucleotide CMC & Regulatory Strategies brings together leading scientists and executives from top biotech and pharma companies to share insights on new developments in analytical characterization, CMC, manufacturing, and regulatory issues. This conference will provide an opportunity to discuss and collaborate on how to optimize product development processes and achieve commercial success.

For more details on the conference, please contact:

For sponsorship information, please contact:

Kristin Skahan

Business Development Manager

Cambridge Healthtech Institute

Phone: 781-972-5431

Email: kskahan@healthtech.com